Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Updated June 2026 · ClinicalTrials.gov

University Hospital, Brest

Reviewed by TrialFinderData Editorial Team · Updated

9 clinical trials · 9 recruiting · OTHER

University Hospital, Brest has 9 clinical trials registered on ClinicalTrials.gov, with 9 actively recruiting participants. The trials listed below cover 17 conditions across the phases listed in the sidebar. Always discuss any specific trial with your physician before contacting a study site.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About University Hospital, Brest\'s Trial Portfolio

University Hospital, Brest is a non-industry sponsor (academic medical center, hospital, foundation, or research network). Non-industry sponsors often investigate novel approaches, rare conditions, and behavioral or surgical interventions that commercial sponsors may not prioritize.

9 of University Hospital, Brest's 9 registered trials are currently recruiting — roughly 100% of the portfolio. A high recruiting share usually points to an active research pipeline with multiple programs at the enrollment stage.

University Hospital, Brest's research footprint spans Venous Thromboembolism (2 trials), Cystic Fibrosis (2), and psychosis-of-childhood-borderline (1) as the top three conditions. The full condition list, sorted by trial count, is in the sidebar.

is the largest single phase in University Hospital, Brest's portfolio at 56% of registered trials. The full phase breakdown appears in the sidebar.

Trials by University Hospital, Brest

RECRUITINGNCT07328152

CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] -...

Combine clinical, biological and morphological data from 14 French and European cohorts into a single database.

Sponsor: University Hospital, BrestEnrolling: 200001 location
Venous Thromboembolism
RECRUITINGNCT06731244

Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )

Venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism (PE) is a frequent disease and the third most common cause of cardiovascular death in the...

Sponsor: University Hospital, BrestEnrolling: 240020 locations
Venous Thromboembolism
RECRUITINGNCT04945278

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability

The main objective of this study is to establish whether there are differences in self-recognition and self/other distinction in subjects with psychological vulnerability compared...

Sponsor: University Hospital, BrestEnrolling: 341 location
Psychosis of Childhood BorderlinePsychotic Disorder
RECRUITINGNCT03525054

Semantic and Syntactic Computerized Analysis of Free Speech

Subtle speech disorganization could be predictive of a transition to schizophrenia of ultra-high-risk patients. The aim of our longitudinal multicenter cohort study is to identify...

Sponsor: University Hospital, BrestEnrolling: 2153 locations
Psychotic DisordersPsychosisSchizophrenia and Related Disorders+2
RECRUITINGNCT04931160

B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome

The objectif is to study the diagnosis performance of the different classification criteria in reference to the gold standard consisting of the diagnosis made by expert doctors...

Sponsor: University Hospital, BrestEnrolling: 10001 location
Sjogren's Syndrome
RECRUITINGNCT05532865

Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking

This study corresponds to a monocentric prospective cohort of adult patients with systemic sclerosis. It will allow the constitution of an organized collection of longitudinal...

Sponsor: University Hospital, BrestEnrolling: 1001 location
Systemic Sclerosis
RECRUITINGNCT04137133

Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine

The objective of this study is to evaluate the relevance of Porphyromonas as a biomarker predicting the risk of P. aeruginosa primocolonization in children form 0 to 18 years old...

Sponsor: University Hospital, BrestEnrolling: 201 location
Cystic Fibrosis
RECRUITINGNCT06045702

Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation

The aim of this observational study is to better understand the role and involvement of the regulatory elements of the CFTR gene, with the aim of better describing the 3D...

Sponsor: University Hospital, BrestEnrolling: 201 location
Cystic FibrosisCongenital Bilateral Absence of Vas DeferensSterility, Male
RECRUITINGNCT06572995

Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock

In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be...

Sponsor: University Hospital, BrestEnrolling: 502 locations
SepsisSeptic ShockHemodynamic Instability+1

How to Approach a Trial Listing

Each trial card above links to a dedicated page with the official ClinicalTrials.gov data plus a plain-English translation of the eligibility criteria. We translate technical terminology (ECOG performance status, hepatic function values, exclusionary lab thresholds) into language that a patient or caregiver can understand, but the original clinical text and the live ClinicalTrials.gov record always govern any actual eligibility decision.

Before contacting a trial site, write down questions for your treating physician using the framework on our 25 Questions guide. Discuss whether the trial fits your treatment plan, what the time commitment looks like, and whether your insurance will cover the standard-of-care portions. Trials are not a substitute for a treatment plan — they are an addition that needs medical guidance to evaluate.

Authoritative Resources

Verify any trial registration directly on ClinicalTrials.gov. For background on the FDA approval pathway that Phase 3 trials feed into, see the FDA drug approval process. For cancer-specific trial guidance, the National Cancer Institute publishes patient-oriented overviews. For global trial registrations beyond the U.S., the WHO ICTRP aggregates registries from around the world.

Frequently Asked Questions

How many clinical trials does University Hospital, Brest have on ClinicalTrials.gov?

University Hospital, Brest has 9 clinical trials registered on the federal ClinicalTrials.gov registry, of which 9 are actively recruiting participants right now. These counts come directly from the ClinicalTrials.gov API and are updated as the registry changes.

What conditions does University Hospital, Brest study?

University Hospital, Brest's registered trials cover 17 conditions on ClinicalTrials.gov, led by Venous Thromboembolism (2 trials), Cystic Fibrosis (2 trials), psychosis-of-childhood-borderline (1 trial), Psychotic Disorder (1 trial), Psychotic Disorders (1 trial). The complete condition list appears in the sidebar of this page; each condition links to a page listing every recruiting trial in that area, regardless of sponsor.

How do I join a University Hospital, Brest clinical trial?

Joining a clinical trial is a medical decision that should always involve your treating physician. Each trial page on this site includes the eligibility criteria translated into plain English alongside the official clinical text, plus the contact information that the sponsor has registered with ClinicalTrials.gov. Bring the trial information to your doctor before reaching out — they can review the full inclusion and exclusion criteria against your medical history and help you decide whether to pursue screening.

What does the trial phase mean?

Phase 1 trials test safety and dosing in small groups (often 20–80 healthy volunteers or patients). Phase 2 trials evaluate efficacy and side effects in larger groups (100–300 patients with the target condition). Phase 3 trials confirm efficacy and monitor safety in the largest groups (300–3,000+ patients) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and effectiveness in real-world use. Some trials register without a phase — common for device, behavioral, or observational studies.

Where does this trial data come from?

All trial data is pulled directly from the ClinicalTrials.gov API v2, the official federal trial registry maintained by the National Library of Medicine at NIH. Under FDAAA 801, most U.S. drug and device trials are required to register, making ClinicalTrials.gov the most comprehensive source. Sponsors are responsible for keeping their listings current; trial status can shift between data refreshes.

How This Sponsor Page Is Built

Every count on this page is derived directly from ClinicalTrials.gov API v2 records. Trial counts include all trials currently registered to this sponsor; the recruiting count reflects trials with status "Recruiting" or equivalent. Plain-English eligibility translations on each linked trial page preserve the original clinical text alongside an accessible version. Read the full methodology for the data pipeline and limitations.

Source: ClinicalTrials.gov API v2, maintained by the National Library of Medicine at NIH. Public domain. Cite as: "TrialFinderData. Data: ClinicalTrials.gov."

Medical disclaimer: This page is informational, not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Last updated 2026-06-26 · 9 trials tracked for University Hospital, Brest.